Foxo technologies expects class a common stock to resume trading, today, november 7, in connection with 1-for-10 reverse stock split

Minneapolis--(business wire)--foxo technologies inc. (nyse american: foxo) (“foxo” or the “company”), a leader in the field of epigenetic biomarker technology, today announced that it expects its class a common stock (the “common stock”) to resume trading today, november 7, 2023, in connection with a 1-for-10 reverse stock split of its issued and outstanding shares of common stock to regain compliance with the continued listing requirements, as set forth in section 1003(f)(v) of the nyse americ.
FOXO Ratings Summary
FOXO Quant Ranking